Most AEC executives would probably agree with Greg Peele, Skanska’s Executive Vice President for operations in North Carolina and Virginia, who states that 2020 was a year “of remarkable growth and transformation” for the science and technology (S+T) sector. The coronavirus pandemic triggered a private- and public-sector recommitment to bringing drug production back to the U.S. Firms like SmithGroup and Payette helped clients convert vacant or underutilized offices into life science spaces.